COMMUNIQUÉS West-GlobeNewswire

-
Aveanna to Participate at the Bank of America Securities 2025 Health Care Conference
22/04/2025 - 13:30 -
Best Female Libido Boosters 2025 and Sexual Enhancement Pills for Women - By Oh Yes
22/04/2025 - 13:34 -
MBX Biosciences to Participate in Citizens and RBC May Investor Conferences
22/04/2025 - 14:00 -
InnovAge to Announce Fiscal Third Quarter 2025 Financial Results and Host Conference Call Tuesday, May 6, 2025
22/04/2025 - 14:00 -
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
22/04/2025 - 14:00 -
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma
22/04/2025 - 14:00 -
Invitation to Orion’s Capital Markets Day on 22 May 2025
22/04/2025 - 08:00 -
Mitolyn Reviews (Investigative Warning 2025): A Comprehensive Review of the Revolutionary Mitochondrial and Cellular Health Supplement
22/04/2025 - 08:23 -
Mitolyn Reviews: Ingredients, Benefits, Pros and Cons! Honest Analysis Inside!
22/04/2025 - 08:24 -
Best Supplements for Menopause Weight Gain and Belly Fat 2025 - Top Supplement for Menopausal Weight Loss By YourBiology
22/04/2025 - 08:25 -
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
22/04/2025 - 09:10 -
Telix Reports US$186M Q1 Revenue, Up 62% YOY
22/04/2025 - 10:17 -
Alpha Bites Gummies Reviews (WARNING) Is It Safe for Men’s Health? Understanding Its Natural Ingredients And Benefits!
22/04/2025 - 10:59 -
UPDATE -- AP Biosciences to Present New Preclinical Data at American Association of Cancer Research Annual Meeting
22/04/2025 - 05:37 -
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years
22/04/2025 - 07:00 -
Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours
22/04/2025 - 07:47 -
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
22/04/2025 - 02:00 -
HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China
22/04/2025 - 02:00 -
UPDATE -- Opreme Films announces “Just Blood”: A Medical Demonstration Poised to Rewrite Theranos Story
22/04/2025 - 04:02
Pages